- Home
- ALZN vs ATXG Comparison
ALZN vs ATXG Comparison
Compare ALZN & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ATXG
- Stock Information
- Founded
- ALZN 2016
- ATXG 2014
- Country
- ALZN United States
- ATXG China
- Employees
- ALZN N/A
- ATXG N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ATXG Professional Services
- Sector
- ALZN Health Care
- ATXG Consumer Discretionary
- Exchange
- ALZN Nasdaq
- ATXG Nasdaq
- Market Cap
- ALZN 6.1M
- ATXG 5.4M
- IPO Year
- ALZN 2021
- ATXG N/A
- Fundamental
- Price
- ALZN $1.00
- ATXG $0.84
- Analyst Decision
- ALZN Strong Buy
- ATXG
- Analyst Count
- ALZN 1
- ATXG 0
- Target Price
- ALZN $20.00
- ATXG N/A
- AVG Volume (30 Days)
- ALZN 210.7K
- ATXG 5.7K
- Earning Date
- ALZN 03-10-2025
- ATXG 02-14-2025
- Dividend Yield
- ALZN N/A
- ATXG N/A
- EPS Growth
- ALZN N/A
- ATXG N/A
- EPS
- ALZN N/A
- ATXG N/A
- Revenue
- ALZN N/A
- ATXG $4,549,310.00
- Revenue This Year
- ALZN $322.64
- ATXG N/A
- Revenue Next Year
- ALZN N/A
- ATXG N/A
- P/E Ratio
- ALZN N/A
- ATXG N/A
- Revenue Growth
- ALZN N/A
- ATXG N/A
- 52 Week Low
- ALZN $0.64
- ATXG $0.49
- 52 Week High
- ALZN $15.06
- ATXG $1.18
- Technical
- Relative Strength Index (RSI)
- ALZN 51.86
- ATXG 49.48
- Support Level
- ALZN $0.95
- ATXG $0.81
- Resistance Level
- ALZN $1.13
- ATXG $0.88
- Average True Range (ATR)
- ALZN 0.09
- ATXG 0.06
- MACD
- ALZN 0.02
- ATXG -0.00
- Stochastic Oscillator
- ALZN 65.13
- ATXG 52.23
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.